Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARBIDOPA\FOSLEVODOPA vs FOSCARNET: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARBIDOPA\FOSLEVODOPA vs FOSCARNET: Safety Overview

Metric FOSCARBIDOPA\FOSLEVODOPA FOSCARNET
Total FAERS Reports 3,161 2,057
Deaths Reported 431 605
Death Rate 13.6% 29.4%
Hospitalizations 1,747 608
Average Patient Age 70.4 yrs 41.8 yrs
% Female Patients 42.2% 40.6%
FDA Approval Date N/A Apr 21, 2021
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription